Abstract 2SPD-006 Table 1
Reference
OS (HR (95% CI
))
Cabozantinib–regorafenib
1.044 (0.692 to 1.576)
Ramucirumab–regorafenib
1.044 (0.726 to 1.501)
Ramucirumab–cabozantinib
1 (0.712 to 1.405)